Clinical Trials Logo

Lower Extremity Wound clinical trials

View clinical trials related to Lower Extremity Wound.

Filter by:
  • None
  • Page 1

NCT ID: NCT05739149 Recruiting - Non-healing Wound Clinical Trials

A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this research is to explore the use of high-resolution microvessel ultrasound imaging system to look for scarring and to monitor wound healing and to see if treatment affects the amount of tiny vessels and circulation around the wound.

NCT ID: NCT05426161 Recruiting - Chronic Pain Clinical Trials

The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower Extremities

Start date: February 7, 2023
Phase: Phase 4
Study type: Interventional

The aim of the study is to investigate the effect of subcutaneous administration of Botulinum toxin A on wound pain, wound healing and safety of treatment.

NCT ID: NCT05243966 Recruiting - Clinical trials for Hidradenitis Suppurativa

Myriad™ Augmented Soft Tissue Reconstruction Registry

MASTRR
Start date: January 10, 2022
Phase:
Study type: Observational [Patient Registry]

This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgical procedure, where the attending physician will use Myriad™ as part of the surgical intervention.

NCT ID: NCT05087758 Recruiting - Diabetic Foot Clinical Trials

Matrion™ Decellularized Placental Membrane in Subjects With Diabetic Foot Ulcers

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

In this study, a novel placental membrane product Matrion™ (LifeNet Health, Inc., Virginia Beach, VA) will be used as a treatment for subjects with diabetic foot ulcers. Matrion is composed of placental membrane derived from donated human birth tissue containing both the innermost amniotic layer and the outermost chorionic layer, inclusive of the trophoblast layer. Matrion is minimally processed and disinfected using a proprietary decellularization technology and terminally sterilized that safely renders the placental membrane acellular and sterile for its intended surgical applications.

NCT ID: NCT04826965 Terminated - Clinical trials for Lower Extremity Wound

VAC Bioburden Wound Care Assessment

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the microbiologic burden and need for further operative debridement of patients undergoing primary surgical debridement of infected tissue, soft tissue abscesses, or traumatic wounds of the upper and lower extremity.

NCT ID: NCT03044132 Completed - Diabetic Foot Ulcer Clinical Trials

DermACELL AWM® in Chronic Wagner Grade 3/4 Diabetic Foot Ulcers

Start date: January 15, 2017
Phase: N/A
Study type: Interventional

This is a prospective, multicenter, clinical research trial evaluating the clinical outcomes of DermACELL AWM in dermal regeneration.